SEC Contract Filing

Filing Date: 2021-03-23

Document Content:
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>tm2026203d1_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<html><head><title></title></head><body><p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><b>Exhibit
 10.2</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>REGISTRATION AND STOCKHOLDER RIGHTS AGREEMENT</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>
<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 36.0pt; margin-top: 0pt; margin-bottom: 0pt;">THIS REGISTRATION AND STOCKHOLDER RIGHTS AGREEMENT (this &ldquo;<b><i><b>Agreement</b></i></b>&#x0094;), dated as of March 17, 2021, is made and entered into by and among Research Alliance Corp. II, a Delaware corporation (the &ldquo;<b><i><b>Company</b></i></b>&#x0094;), Research Alliance Holdings II LLC, a Delaware limited liability company (the &ldquo;<b><i><b>Sponsor</b></i></b>&#x0094;) and the undersigned parties listed on the signature page hereto under &ldquo;Holders&#x0094; (each such party, together with the Sponsor and any person or entity who hereafter becomes a party to this Agreement pursuant to <u>Section 5.2</u> of this Agreement, a &ldquo;<b><i><b>Holder</b></i></b>&#x0094; and collectively the &ldquo;<b><i><b>Holders</b></i></b>&#x0094;).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt;"><b>RECITALS</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>
<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 36.0pt; margin-top: 0pt; margin-bottom: 0pt;"><b>WHEREAS</b>, the Company has 3,737,500 shares of Class B common stock, par value $0.0001 per share (the &ldquo;<b><i><b>Founder Shares</b></i></b>&#x0094;), issued and outstanding, up to 487,500 of which will be forfeited to the Company for no consideration depending on the extent to which the underwriters of the Company&#x2019;s initial public offering exercise their over-allotment option;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>
<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 36.0pt; margin-top: 0pt; margin-bottom: 0pt;"><b>WHEREAS</b>, the Founder Shares are convertible into shares of the Company&#x2019;s Class A common stock, par value $0.0001 per share (the <b>&ldquo;<i><b>Common</b></i> <i><b>Stock</b></i></b>&#x0094;), on the terms and conditions provided in the Company&#x2019;s amended and restated certificate of incorporation;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>
<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 36.0pt; margin-top: 0pt; margin-bottom: 0pt;"><b>WHEREAS</b>, on March 17, 2021, the Company and the Sponsor entered into that certain Private Placement Share Purchase Agreement (the &ldquo;<b><i><b>Private Placement Share Purchase Agreement</b></i></b>&#x0094;), pursuant to which the Sponsor agreed to purchase up to 460,000 private placement shares (or up to 499,000 shares to the extent that the over-allotment option in connection with the Company&#x2019;s initial public offering is exercised) (the &ldquo;<b><i><b>Private Placement Shares</b></i></b>&#x0094;) in a private placement transaction occurring simultaneously with the closing of the Company&#x2019;s initial public offering;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>
<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 36.0pt; margin-top: 0pt; margin-bottom: 0pt;"><b>WHEREAS</b>, in order to finance the Company&#x2019;s transaction costs in connection with its search for and consummation of an initial Business Combination (as defined below), the Sponsor or an affiliate of the Sponsor or certain of the Company&#x2019;s officers and directors may loan to the Company funds as the Company may require, of which up to 1,500,000 of such loans may be convertible into private placement-equivalent shares (&ldquo;<b><i><b>Working Capital Shares</b></i></b>&#x0094;) at a price of $10.00 per share at the option of the lender; and</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>
<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 36.0pt; margin-top: 0pt; margin-bottom: 0pt;"><b>WHEREAS</b>, the Company and the Holders desire to enter into this Agreement, pursuant to which the Company shall grant the Holders certain registration rights with respect to certain securities of the Company, as set forth in this Agreement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>
<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 36.0pt; margin-top: 0pt; margin-bottom: 0pt;"><b>NOW</b>,<b> THEREFORE</b>, in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt;"><b>ARTICLE I</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bo